• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Teleflex to Present at the BofA Securities 2025 Health Care Conference

    4/30/25 6:45:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care
    Get the next $TFX alert in real time by email

    WAYNE, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE:TFX), will be presenting at the BofA Securities 2025 Health Care Conference at the Encore Hotel in Las Vegas, Nevada, on Wednesday, May 14, 2025, at 1:40 p.m. (PT).

    A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at teleflex.com.

    About Teleflex Incorporated

    As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.

    Teleflex is the home of Arrow™, Barrigel™, Deknatel™, QuikClot™, LMA™, Pilling™, Rüsch™, UroLift™ and Weck™ – trusted brands united by a common sense of purpose.

    At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com.

    Contacts:

    Teleflex

    Lawrence Keusch

    Vice President, Investor Relations and Strategy Development

    [email protected]

    610-948-2836



    Primary Logo

    Get the next $TFX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TFX

    DatePrice TargetRatingAnalyst
    3/4/2025$235.00 → $140.00Neutral → Underperform
    BofA Securities
    2/28/2025$220.00 → $155.00Outperform → Sector Perform
    RBC Capital Mkts
    2/28/2025Outperform → Mkt Perform
    Raymond James
    2/28/2025$255.00 → $140.00Overweight → Neutral
    Piper Sandler
    2/27/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    7/1/2024$205.00 → $245.00Neutral → Overweight
    Piper Sandler
    12/4/2023$261.00Equal-Weight → Overweight
    Morgan Stanley
    6/21/2023Buy → Hold
    Needham
    More analyst ratings

    $TFX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Teleflex downgraded by BofA Securities with a new price target

      BofA Securities downgraded Teleflex from Neutral to Underperform and set a new price target of $140.00 from $235.00 previously

      3/4/25 7:44:32 AM ET
      $TFX
      Medical/Dental Instruments
      Health Care
    • Teleflex downgraded by RBC Capital Mkts with a new price target

      RBC Capital Mkts downgraded Teleflex from Outperform to Sector Perform and set a new price target of $155.00 from $220.00 previously

      2/28/25 7:34:55 AM ET
      $TFX
      Medical/Dental Instruments
      Health Care
    • Teleflex downgraded by Raymond James

      Raymond James downgraded Teleflex from Outperform to Mkt Perform

      2/28/25 7:34:03 AM ET
      $TFX
      Medical/Dental Instruments
      Health Care

    $TFX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Duncan Candace H was granted 1,051 shares, increasing direct ownership by 22% to 5,907 units (SEC Form 4)

      4 - TELEFLEX INC (0000096943) (Issuer)

      5/13/25 5:03:30 PM ET
      $TFX
      Medical/Dental Instruments
      Health Care
    • Director Patil Neena M was granted 1,051 shares, increasing direct ownership by 67% to 2,626 units (SEC Form 4)

      4 - TELEFLEX INC (0000096943) (Issuer)

      5/13/25 5:03:06 PM ET
      $TFX
      Medical/Dental Instruments
      Health Care
    • Director Heinmiller John C was granted 1,051 shares, increasing direct ownership by 34% to 4,176 units (SEC Form 4)

      4 - TELEFLEX INC (0000096943) (Issuer)

      5/13/25 5:03:20 PM ET
      $TFX
      Medical/Dental Instruments
      Health Care

    $TFX
    SEC Filings

    See more
    • SEC Form SD filed by Teleflex Incorporated

      SD - TELEFLEX INC (0000096943) (Filer)

      5/29/25 10:58:02 AM ET
      $TFX
      Medical/Dental Instruments
      Health Care
    • Teleflex Incorporated filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - TELEFLEX INC (0000096943) (Filer)

      5/15/25 4:06:35 PM ET
      $TFX
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-Q filed by Teleflex Incorporated

      10-Q - TELEFLEX INC (0000096943) (Filer)

      5/1/25 11:49:55 AM ET
      $TFX
      Medical/Dental Instruments
      Health Care